Obstetrical complications associated with abnormal maternal serum markers analytes

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Clinical Genetics

Background:

• Maternal serum marker screening is used to assess aneuploidy risk.
• Abnormal analyte levels can be associated with various adverse pregnancy outcomes.
• Current guidelines aim to manage pregnancies with abnormal screening results.

Purpose of the Study:

• To review obstetrical outcomes linked to abnormal maternal serum marker levels.
• To provide guidance for managing pregnancies with abnormal marker levels.
• To assess the utility of these markers in prenatal screening.

Main Methods:

• Systematic literature search of Medline and Cochrane Library (1966-2007).
• Inclusion of all study types, prioritizing RCTs and cohort studies.
• Evidence evaluated using Canadian Task Force on Preventive Health Care guidelines.

Main Results:

• Unexplained abnormal marker levels are associated with increased adverse obstetrical outcomes.
• Specific analyte patterns (e.g., low PAPP-A, elevated AFP) correlate with risks like IUGR and gestational hypertension.
• False positives can cause undue stress; no universal management protocol exists for all abnormal results.

Conclusions:

• Abnormal maternal serum marker levels can identify pregnancies at risk for adverse outcomes.
• Clinical management should focus on abnormal analyte values rather than solely on aneuploidy screening results.
• Further research is needed to establish optimal surveillance and management protocols.